Genetic Analysis AS (NGM:GEAN)

Genetic Analysis AS Statistics

Total Valuation

NGM:GEAN has a market cap or net worth of SEK 30.56 million. The enterprise value is 25.92 million.

Market Cap	30.56M
Enterprise Value	25.92M

Important Dates

The last earnings date was Monday, February 17, 2025.

Earnings Date	Feb 17, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:GEAN has 49.38 million shares outstanding. The number of shares has increased by 28.55% in one year.

Current Share Class	n/a
Shares Outstanding	49.38M
Shares Change (YoY)	+28.55%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.60%
Owned by Institutions (%)	16.37%
Float	13.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.52
PB Ratio	1.39
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.80
EV / Sales	1.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.97

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.37.

Current Ratio	1.88
Quick Ratio	1.81
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-0.93
Interest Coverage	-14.62

Financial Efficiency

Return on equity (ROE) is -54.21% and return on invested capital (ROIC) is -25.29%.

Return on Equity (ROE)	-54.21%
Return on Assets (ROA)	-18.53%
Return on Invested Capital (ROIC)	-25.29%
Return on Capital Employed (ROCE)	-46.10%
Revenue Per Employee	959,504
Profits Per Employee	-685,115
Employee Count	21
Asset Turnover	0.43
Inventory Turnover	2.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.42% in the last 52 weeks. The beta is 1.90, so NGM:GEAN's price volatility has been higher than the market average.

Beta (5Y)	1.90
52-Week Price Change	-54.42%
50-Day Moving Average	0.66
200-Day Moving Average	0.68
Relative Strength Index (RSI)	49.54
Average Volume (20 Days)	41,322

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:GEAN had revenue of SEK 20.15 million and -14.39 million in losses. Loss per share was -0.33.

Revenue	20.15M
Gross Profit	17.12M
Operating Income	-13.85M
Pretax Income	-14.39M
Net Income	-14.39M
EBITDA	-8.74M
EBIT	-13.85M
Loss Per Share	-0.33

Balance Sheet

The company has 13.03 million in cash and 8.13 million in debt, giving a net cash position of 4.90 million or 0.10 per share.

Cash & Cash Equivalents	13.03M
Total Debt	8.13M
Net Cash	4.90M
Net Cash Per Share	0.10
Equity (Book Value)	21.91M
Book Value Per Share	0.44
Working Capital	9.89M

Cash Flow

In the last 12 months, operating cash flow was -8.28 million and capital expenditures -446,167, giving a free cash flow of -8.72 million.

Operating Cash Flow	-8.28M
Capital Expenditures	-446,167
Free Cash Flow	-8.72M
FCF Per Share	-0.18

Margins

Gross margin is 84.95%, with operating and profit margins of -68.72% and -71.40%.

Gross Margin	84.95%
Operating Margin	-68.72%
Pretax Margin	-71.40%
Profit Margin	-71.40%
EBITDA Margin	-43.38%
EBIT Margin	-68.72%
FCF Margin	n/a

Dividends & Yields

NGM:GEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.55%
Shareholder Yield	-28.55%
Earnings Yield	-47.08%
FCF Yield	-28.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:GEAN has an Altman Z-Score of 0.16. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	n/a